Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Rational design of an NLRP3 inhibitor with superior efficacy and safety for gout therapy
Kong, Y., Su, M., Jiang, C., Feng, H., Hu, Y., Li, D., Mao, Z., Liu, F., Zhu, F., Guo, Y., Ren, S., Chi, M., Qiu, T., Yuan, Y., Huang, W., Ma, L. & Chen, X., Mar 5 2026, In: European Journal of Medicinal Chemistry. 305, 118578.Research output: Contribution to journal › Article › peer-review
-
Computational Design and In Vitro and In Vivo Characterization of an ApoE-Based Synthetic High-Density Lipoprotein for Sepsis Therapy
Guo, L., Yuan, Y., Zheng, F., Zhan, C. & Li, X., Mar 2025, In: Biomolecules. 15, 3, 397.Research output: Contribution to journal › Article › peer-review
Open Access -
Design and synthesis of JNK1-targeted PROTACs and research on the activity
Guo, Y., Liu, F., Chi, M., Qian, H., Zhang, Y., Yuan, Y., Hou, S., Chen, X. & Ma, L., Jan 2025, In: Bioorganic Chemistry. 154, 108044.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations -
Discovery of a selective and potent inhibitor of c-Jun N-terminal kinase 1 with anti-pulmonary fibrosis effect
Ren, S., Liu, F., Chi, M., Liu, J., Huang, Y., Huang, W., Gu, W., Yuan, Y., Hou, S., Chen, X. & Ma, L., Feb 1 2025, In: Bioorganic and Medicinal Chemistry Letters. 116, 130044.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations -
Discovery of Dual BCL-xL/BCL-w Degraders by Exploiting the Bis(sulfonyl)benzene Ring of ABT-263 as a Linkage Vector
Poddar, S. K., Yang, Y., Pal, P., Jin, Z., Pei, J., Xiao, Y., Hu, W., Zhang, P., Adekunbi, P., Thummuri, D., Yuan, Y., Lv, D., Pelletier, J. P. R., Zhang, W., Zhou, D. & Zheng, G., Sep 11 2025, In: Journal of Medicinal Chemistry. 68, 17, p. 18684-18702 19 p.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations
Datasets
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset